Sfoglia per AUTORE
RIZZO L
Collezione ASL Biella

  

Items : 3

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.

2023
ASL Biella
AOU Città della Salute di Torino
AOU Novara
AOU Alessandria

Latagliata R; Zini G; D'Errigo MG; Bova I; Rizzo L; Riva M; Niscola P; Santini V; Breccia M; Giai V; Poloni A; Patriarca A; Crisà E; Capodanno I; Salutari P; Reda G; Cascavilla N; Ferrero D; Guarini A; Tripepi G; Iannì G; Russo E; Castelli A; Fattizzo B; Beltrami G; Bocchia M; Molteni A; Fenaux P; Germing U; et alii...

Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective? in HemaSphere / Hemasphere. 2023 Mar 27;7(4):e867. doi: 10.1097/HS9.0000000000000867. eCollection 2023 Apr.

2023
ASL Biella

Barcellini W; Molteni A; Cairoli R; Castelli A; Borin L; Lussana F; Ferrari S; Mazzon F; Rizzo L; Bosi A; Riva M; Fattizzo B;

Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study in Blood

2022
ASL Biella

Bosi A; Fattizzo B; Rizzo L; Ferrari S; Lussana F; Borin LM; Castelli A; Bianchi P; Barcellini W; Cairoli R; Molteni A; Riva M;